1 / 7

APAC Healthcare AI Market Outlook 2021 - Industry Statistics Analysis by 2027

Asia Pacific Healthcare AI Market is predicted to record a value of USD 4.1 billion by the end of 2027. <br>Artificial Intelligence (AI) has revolutionized the healthcare sector. It helps healthcare professionals in organizational management processes while supporting them in various phases of patient care. Using AI mainly helps in early diagnosis, lessening therapeutic errors and increasing overall patient safety.<br>

Djay123
Download Presentation

APAC Healthcare AI Market Outlook 2021 - Industry Statistics Analysis by 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Asia Pacific Healthcare AI Market 2021 Industry Trends | Growth Dynamics To 2027: Graphical Research ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  2. Asia Pacific Healthcare AI Market is predicted to record a value of USD 4.1 billion by the end of 2027. Artificial Intelligence (AI) has revolutionized the healthcare sector. It helps healthcare professionals in organizational management processes while supporting them in various phases of patient care. Using AI mainly helps in early diagnosis, lessening therapeutic errors and increasing overall patient safety. Growing research & development activities in the field of artificial intelligence have majorly benefitted the healthcare sector across the Asia Pacific region. Additionally, advanced innovations, increasing AI-based applications in healthcare and establishing an infrastructure compatible with latest AI technologies will significantly contribute to the adoption of AI in healthcare. Many key players and government bodies are taking initiatives to promote artificial intelligence to have an integral part in the healthcare sector. Citing an instance, in the year 2010, GlaxoSmithKline and Singapore Economic Development Board (EDB) provided funds to form the NUS (National University of Singapore) Initiative to Improve Health in Asia (NIHA). Under this initiative, the public health services across Asia Pacific will be fortified through recent research, significant investments and stringent regulations. Healthcare facilities in many nations across Asia Pacific are frequently pushed to their limits owing to the lack of skilled healthcare professionals. As per an estimate by the World Health Organization, by 2030, Asia will need over 12 million new healthcare professionals, a staggering rise of over 70% when compared to previous figures. ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  3. Get sample copy of this research report @ https://bit.ly/3cfFWbI • This issue is not limited to developing nations. Even developed countries like Singapore, Korea and Japan are facing a severe lack of human capital. In such cases, artificial intelligence can seamlessly bridge the gap in healthcare resources and reduce the direct dependency on human capital. AI not only increases the accessibility of medical resources but also improves the efficiency of diagnosing and treating diseases. • Various applications of AI in healthcare sector • Drug Discovery • There has been a significant rise in the usage of artificial intelligence in drug discovery for obtaining productive, cost-effective and faster results in Asia Pacific. In fact, the regional healthcare AI market revenue from drug discovery applications surpassed USD 71 million in 2020. • A recent research journal indicated that AI tools are extensively capable to process big data and help create models of unknown cellular mechanisms. AI technologies can come in handy in the synthesis of information for future reference, executing pre-clinical setups, establishing clinical biomarkers and generating potential new drug candidates. • Citing an instance, Insilico Medicine, a Hong Kong-based company, has developed an in-depth drug discovery system. The system uses millions of samples and data types to identify disease signatures and for recognizing possible targets from billions of molecules that already exist. It is developments like these that provide a platform for the segment to gain some growth impetus during the stipulated timeframe. • Request for customization @ https://bit.ly/3O9PsKR ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  4. Medical Imaging & Diagnosis • Growing investments in emerging AI healthcare companies, AI’s potential of transforming patient management and its increasing adoption in disease diagnosis are potential growth prospects for the medical imaging & diagnosis segment. It registered a revenue of USD 68 million in 2020 owing to the aforementioned factors. • The aim of using AI in medical imaging and diagnosis is to improve the production of high-quality images and their interpretation. For instance, the Australian Society of Medical Imaging and Radiation Therapy is encouraging the usage of Artificial Intelligence in medical imaging. Therefore, AI has turned out to be an efficient data source for disease diagnosis, which in turn helps in the proliferation of the market. • Robust regional grounds for healthcare AI market • The market for healthcare AI in China exceeded a value of USD 70 million in 2020. This is owing to the developments in AI and its capability of infusing strength into conventional industries. China has the most AI hubs and is currently witnessing a digital revolution in the healthcare sector. • The Chinese market covers various areas like health management, online consultations and drug development. At present, over 129 companies from the country are actively involved in healthcare AI. Out of them, over 55 companies are into medical imaging, making it over 43% of the total industry players in the country. ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  5. Similarly, Japan healthcare AI market is predicted to grow at a rate of 47.8% and reaching a value of USD 1.2 billion by the end of 2027. This growth can be credited to rapid developments in healthcare infrastructure, growing geriatric population and increased expenditure on healthcare. • Over 35.6 million people or around 28% of the population was of the age of 65 and above in 2019. This number is predicted to grow in such a way that by 2036, over one third of Japan’s total population will be of age 65 and above. The Japanese government also is heavily investing in healthcare infrastructure. • In short, growing awareness regarding the potential of artificial intelligence, lack of skilled healthcare workers and increasing geriatric population contribute will to the growth of the healthcare AI market in Asia Pacific. • Segmentation of Asia Pacific Healthcare AI Market: • Asia Pacific Market, By Application • Medical Imaging & Diagnosis • Drug Discovery • Therapy Planning • Hospital Workflow • Wearables • Virtual Assistants • Others ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  6. About Graphical Research: Graphical Research is a business research firm that provides industry insights, market forecast and strategic inputs through granular research reports and advisory services. We publish targeted research reports with an aim to address varied customer needs, from market penetration and entry strategies to portfolio management and strategic outlook. We understand that business requirements are unique: our syndicate reports are designed to ensure relevance for industry participants across the value chain. We also provide custom reports that are tailored to the exact needs of the customer, with dedicated analyst support across the purchase lifecycle. Contact Us: Parikhit B. Corporate sales, Graphical Research Email:sales@graphicalresearch.comWeb: https://www.graphicalresearch.com ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

  7. Stay In Touch With Us For: Website: www.graphicalresearch.com Social Media: Assured Quality On-Time Delivery Payment Security Industry Experts ©2018 Graphical Research. All rights reserved. www.graphicalresearch.com

More Related